EverSource Wealth Advisors LLC Has $41,000 Stake in Revvity, Inc. (NYSE:RVTY)

EverSource Wealth Advisors LLC increased its position in Revvity, Inc. (NYSE:RVTYFree Report) by 74.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 392 shares of the company’s stock after buying an additional 167 shares during the period. EverSource Wealth Advisors LLC’s holdings in Revvity were worth $41,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Czech National Bank increased its stake in shares of Revvity by 0.5% during the 1st quarter. Czech National Bank now owns 21,713 shares of the company’s stock worth $2,280,000 after purchasing an additional 99 shares during the last quarter. Garrison Asset Management LLC raised its holdings in Revvity by 0.5% during the second quarter. Garrison Asset Management LLC now owns 21,328 shares of the company’s stock valued at $2,236,000 after buying an additional 103 shares in the last quarter. TriaGen Wealth Management LLC raised its holdings in Revvity by 2.3% during the second quarter. TriaGen Wealth Management LLC now owns 4,767 shares of the company’s stock valued at $500,000 after buying an additional 107 shares in the last quarter. Guinness Asset Management LTD lifted its position in shares of Revvity by 3.3% in the second quarter. Guinness Asset Management LTD now owns 3,587 shares of the company’s stock worth $376,000 after buying an additional 116 shares during the last quarter. Finally, Inspire Investing LLC boosted its stake in shares of Revvity by 2.9% during the 1st quarter. Inspire Investing LLC now owns 4,190 shares of the company’s stock worth $440,000 after acquiring an additional 117 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Barclays boosted their target price on Revvity from $115.00 to $125.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 30th. Leerink Partners started coverage on shares of Revvity in a report on Monday, July 8th. They set an “outperform” rating and a $125.00 price objective for the company. Leerink Partnrs upgraded shares of Revvity to a “strong-buy” rating in a report on Monday, July 8th. Citigroup upped their price target on shares of Revvity from $135.00 to $145.00 and gave the company a “buy” rating in a report on Tuesday, July 30th. Finally, Jefferies Financial Group lifted their price objective on Revvity from $115.00 to $125.00 and gave the stock a “hold” rating in a research note on Monday, July 29th. Eight research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $125.53.

Get Our Latest Analysis on RVTY

Revvity Stock Performance

Shares of NYSE RVTY opened at $126.06 on Friday. The firm has a market capitalization of $15.55 billion, a price-to-earnings ratio of 104.18, a PEG ratio of 2.90 and a beta of 1.05. Revvity, Inc. has a one year low of $79.50 and a one year high of $128.15. The business has a fifty day simple moving average of $120.44 and a 200 day simple moving average of $111.13. The company has a current ratio of 2.27, a quick ratio of 1.98 and a debt-to-equity ratio of 0.40.

Revvity (NYSE:RVTYGet Free Report) last released its quarterly earnings data on Monday, July 29th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.10. Revvity had a net margin of 6.26% and a return on equity of 7.34%. The company had revenue of $691.70 million during the quarter, compared to the consensus estimate of $690.33 million. During the same period last year, the firm earned $1.21 EPS. The firm’s revenue for the quarter was down 2.5% compared to the same quarter last year. Sell-side analysts expect that Revvity, Inc. will post 4.75 EPS for the current year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 8th. Shareholders of record on Friday, October 18th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.22%. The ex-dividend date is Friday, October 18th. Revvity’s payout ratio is 23.14%.

Insider Activity

In related news, insider Joel S. Goldberg sold 3,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total transaction of $412,510.00. Following the completion of the transaction, the insider now owns 33,400 shares in the company, valued at approximately $3,936,524. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.60% of the company’s stock.

About Revvity

(Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Featured Articles

Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity, Inc. (NYSE:RVTYFree Report).

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.